Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.9% sodium chloride2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--4件: 6, 14, 51, 53 💬
210% intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---1件: 14 💬
310% liquid formulation of human immunoglobulin----1件: 14 💬
4: immunoglobulina umana normale 10% per somministrazione endovenosa----1件: 14 💬
5Act-HiB1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---4件: 14, 61, 62, 222 💬
6Acthar1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 14, 46, 49, 50, 66, 84, 222 💬
7Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14 💬
8Anti-C5 antibody----4件: 11, 14, 62, 109 💬
9Anti-Thymocyte Globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
10ARGX-113----5件: 11, 14, 35, 53, 63 💬
11ARGX-117----1件: 14 💬
12ARGX-117 IV----1件: 14 💬
13Batoclimab1件: Batoclimab1件: Batoclimab 💬1件: FCGRT 💬-2件: 11, 14 💬
14Batoclimab 340 mg SC weekly1件: Batoclimab1件: Batoclimab 💬1件: FCGRT 💬-2件: 11, 14 💬
15Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly1件: Batoclimab1件: Batoclimab 💬1件: FCGRT 💬-1件: 14 💬
16Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14 💬
17BIVV020----2件: 14, 61 💬
18Carmustine1件: Carmustine1件: Carmustine 💬--5件: 11, 13, 14, 28, 60 💬
19Chloride1件: Chloride ion---28件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬
20Clorfenamina1件: Chlorpheniramine1件: Chlorphenamine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 14 💬
21CLORFENAMINA MALEATO1件: Chlorpheniramine1件: Chlorphenamine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 14 💬
22Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬
23Cytarabine1件: Cytarabine1件: Cytarabine 💬--7件: 11, 13, 14, 25, 49, 60, 65 💬
24Dexamethasone1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
25Drug:----3件: 14, 46, 113 💬
26ECULIZUMAB1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 11, 13, 14, 61, 62, 109, 222 💬
27EFGARTIGIMOD ALFA1件: Efgartigimod alfa1件: Efgartigimod alfa 💬1件: FCGRT 💬-6件: 11, 14, 35, 53, 63, 162 💬
28Efgartigimod PH20 SC----5件: 11, 14, 35, 63, 162 💬
29Efgartigimod PH20 SC in stage B----1件: 14 💬
30Etoposide1件: Etoposide1件: Etoposide 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
31FAMPRIDINE1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
32FAMPYRA1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
33Fibrinogen1件: Fibrinogen human---2件: 14, 65 💬
34Fibrinogen concentrate1件: Fibrinogen human---1件: 14 💬
35FINGOLIMOD1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
36FINGOLIMOD HYDROCHLORIDE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
37Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)1件: Human immunoglobulin G---3件: 14, 43, 45 💬
38FTY720----2件: 13, 14 💬
39FTY720I----1件: 14 💬
40Gammanorm----2件: 14, 65 💬
41Gilenya1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 2, 13, 14 💬
42GILENYA 0,5 mg cápsulas duras1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 14 💬
43Group C meningococcal conjugate vaccine----1件: 14 💬
44H.P. Acthar® Gel1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 14 💬
45HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---2件: 13, 14 💬
46Haemophilus type b vaccine (conjugated)----1件: 14 💬
47HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---5件: 2, 6, 13, 14, 46 💬
48Hematopoietic Stem Cell Transplantation----12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬
49Hidrocloruro de fingolimod1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
50Hizentra1件: Human immunoglobulin G---4件: 14, 50, 51, 65 💬
51Hizentra®1件: Human immunoglobulin G---2件: 14, 65 💬
52HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G---4件: 14, 50, 63, 65 💬
53Human normal 10% immunoglobulin for intravenous administration----1件: 14 💬
54Human normal 10% immunoglobulin for intravenous administrationn----1件: 14 💬
55Human normal immunoglobulin1件: Human immunoglobulin G---9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
56HUMAN NORMAL IMMUNOGLOBULIN (IV)1件: Human immunoglobulin G---4件: 11, 14, 63, 65 💬
57Human normal immunoglobulin (IVIg)1件: Human immunoglobulin G---3件: 14, 50, 65 💬
58Human normal immunoglobulin (SCIg)1件: Human immunoglobulin G---1件: 14 💬
59Human normal immunoglobulin for intravenous administration1件: Human immunoglobulin G---3件: 14, 51, 65 💬
60Human normal immunoglobulin G (IgG > 98% purity)1件: Human immunoglobulin G---3件: 14, 63, 65 💬
61Hyaluronidase2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬		--5件: 14, 28, 51, 65, 331 💬
62HyQvia2件: Human immunoglobulin G,
Hyaluronidase (human recombinant)		---2件: 14, 65 💬
63I10----1件: 14 💬
64I10E----3件: 14, 63, 65 💬
65IGIV, 10%----2件: 14, 65 💬
66IgPro10----3件: 14, 51, 65 💬
67IgPro20----4件: 14, 50, 51, 65 💬
68IgPro20 (high dose)----1件: 14 💬
69IgPro20 (low dose)----1件: 14 💬
70IGVENA*FL 200ML 10G+SET----2件: 14, 50 💬
71Immune globulin----3件: 11, 13, 14 💬
72Immune Globulin 10% Intravenous Solution----1件: 14 💬
73Immune Globulin Intravenous (human), 10%----2件: 14, 65 💬
74Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified----1件: 14 💬
75Immune Globulin Subcutaneous (Human)----2件: 14, 65 💬
76Immunoglobulin----3件: 13, 14, 63 💬
77IMMUNOGLOBULIN G----8件: 2, 11, 13, 14, 49, 50, 63, 65 💬
78Immunoglobulin perfusion----1件: 14 💬
79IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa----1件: 14 💬
80Immunoglobuline G----1件: 14 💬
81Immunoglobulins----1件: 14 💬
82Immunoglobulins, normal human, for extravascular adm.----1件: 14 💬
83Immunoglobulins, normal human, for intravascular adm.----2件: 14, 15 💬
84Intratect----4件: 13, 14, 35, 65 💬
85Intravenous immune globulin G----1件: 14 💬
86Intravenous Immunoglobulin----7件: 13, 14, 35, 38, 39, 51, 309 💬
87Intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---4件: 14, 17, 164, 296 💬
88IQYMUNE----1件: 14 💬
89IVIG1件: Human immunoglobulin G---7件: 11, 13, 14, 17, 50, 51, 65 💬
90J07AH07----1件: 14 💬
91KIOVIG1件: Human immunoglobulin G---2件: 14, 65 💬
92KIOVIG 100 mg/ml solution for infusion1件: Human immunoglobulin G---2件: 14, 65 💬
93Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14 💬
94Lipoic acid1件: Lipoic acid---5件: 2, 5, 13, 14, 20 💬
95MabThera1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬
96MABTHERA - 1 FIALA 500 MG 50 ML1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 14, 53 💬
97MD1003----5件: 2, 10, 13, 14, 20 💬
98Melphalan1件: Melphalan1件: Melphalan 💬--15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬
99Menjugate----1件: 14 💬
100Methylprednisolon1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬4件: 13, 14, 51, 66 💬
101Methylprednisolon (Solu-Medrol)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14 💬
102Methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
103Methylprednisolone (Solu-Medrol)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14 💬
104Metilprednisolone sodio succinato----3件: 13, 14, 56 💬
105N. MENINGITIDIS GROUP C POLYSACCHARIDE----1件: 14 💬
106NewGam----3件: 14, 63, 65 💬
107Nipocalimab1件: Nipocalimab1件: Nipocalimab 💬1件: FCGRT 💬-6件: 11, 14, 46, 49, 53, 61 💬
108NPB-01----3件: 13, 14, 162 💬
109PANZYGA----1件: 14 💬
110PARACETAMOLO----9件: 2, 11, 14, 19, 28, 53, 61, 63, 300 💬
111Placebo----28件: 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
112PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----2件: 13, 14 💬
113PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
114Prednisone1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
115Prevenar 1312件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---5件: 13, 14, 46, 96, 222 💬
116Prevenar 13 sospensione per iniezione12件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---1件: 14 💬
117PRIVIGEN1件: Human immunoglobulin G---4件: 11, 14, 51, 65 💬
118Privigen®1件: Human immunoglobulin G---3件: 14, 63, 65 💬
119Recombinant human hyaluronidase2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬		--3件: 14, 28, 65 💬
120RHuPH20----2件: 13, 14 💬
121RITUXIMAB1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
122Rituximab (genetical recombination)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 14 💬
123ROZANOLIXIZUMAB1件: Rozanolixizumab1件: Rozanolixizumab 💬1件: FCGRT 💬-3件: 11, 14, 63 💬
124RVG 51680----1件: 14 💬
125RVG 56083----1件: 14 💬
126SAR445088 (formerly BIVV020)----1件: 14 💬
127SAR445088 (IV)----1件: 14 💬
128SAR445088 (SC)----1件: 14 💬
129Sodium chloride2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--20件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬
130Sodium Chloride 0.9%2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--2件: 14, 227 💬
131SOLIRIS1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 11, 13, 14, 61, 62, 109, 222 💬
132SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----3件: 13, 14, 53 💬
133Subcutaneous immune globulin G----1件: 14 💬
134Subcutaneous immunoglobulin----1件: 14 💬
135Subcuvia----3件: 14, 49, 65 💬
136TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE----1件: 14 💬
137TAK-771----2件: 14, 65 💬
138Tetanus toxoid1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---4件: 13, 14, 46, 50 💬
139TRIMETON - 10 MG/1 ML SOLUZIONE INIETTABILE 5 FIALE 1 ML----1件: 14 💬
140UCB7665----3件: 11, 14, 63 💬
141VACCINO PNEUMOCOCCICO SACCARIDICO----1件: 14 💬
142Vivaglobin----2件: 14, 65 💬